New combo therapy shows promise for aggressive lung cancer
NCT ID NCT05380713
First seen Jan 03, 2026 · Last updated May 14, 2026 · Updated 23 times
Summary
This study tested a new approach for people with malignant mesothelioma, a rare cancer linked to asbestos. Thirty participants received either radiation alone or radiation plus a low-dose chemotherapy drug before surgery. After surgery, some also got two immunotherapy drugs to try to prevent the cancer from coming back. The goal was to see if the combination boosted the immune system's ability to fight the tumor.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MESOTHELIOMA, MALIGNANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Conditions
Explore the condition pages connected to this study.